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Abstract 
The amount of photolesions produced in DNA after exposure to physiological doses of 
ultraviolet radiation (UVR) can be estimated with high sensitivity and at low cost 
through an immunological assay, ELISA, which, however, provides only a relative 
estimate that cannot be used for comparisons between different photolesions such as 
cyclobutane pyrimidine dimer (CPD) and pyrimidine(6-4)pyrimidone photoproduct 
(64PP) or for analysis of the genotoxicity of photolesions on a molecular basis. To solve 
this drawback of ELISA, we introduced a set of UVR-exposed, calibration DNA whose 
photolesion amounts were predetermined and estimated the absolute molecular amounts 
of CPDs and 64PPs produced in mouse skin exposed to UVC and UVB. We confirmed 
previously reported observations that UVC induced more photolesions in the skin than 
UVB at the same dose, and that both types of UVR produced more CPDs than 64PPs. 
The UVR protection abilities of the cornified and epidermal layers for the lower tissues 
were also evaluated quantitatively. We noticed that the values of absorbance obtained in 
ELISA were not always proportional to the molecular amounts of the lesion, especially 
for CPD, cautioning against the direct use of ELISA absorbance data for estimation of 
the photolesion amounts. We further estimated the mutagenicity of a CPD produced by 
UVC and UVB in the epidermis and dermis using the mutation data from our previous 
studies with mouse skin and found that CPDs produced in the epidermis by UVB were 
more than two-fold mutagenic than those by UVC, which suggests that the properties of 
CPDs produced by UVC and UVB might be different. The difference may originate 
from the wavelength-dependent methyl CpG preference of CPD formation. In addition, 
the mutagenicity of CPDs in the dermis was lower than that in the epidermis 
irrespective of the UVR source, suggesting a higher efficiency in the dermis to reduce 
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the genotoxicity of CPDs produced within it. We also estimated the minimum amount 
of photolesions required to induce the mutation induction suppression (MIS) response 
in the epidermis to be around 15 64PPs or 100 CPDs per million bases in DNA as the 
mean estimate from UVC and UVB-induced MIS. 
 
Introduction 
Ultraviolet radiation (UVR) induces mutations in the cellular genome, which can lead to 
carcinogenesis in repetitively UVR-exposed tissues, as evidenced in sun-exposed 
human skin.1–4 UVR produces base photolesions such as cyclobutane pyrimidine dimers 
(CPDs) and pyrimidine(6-4)pyrimidone photoproducts (64PPs) at dipyrimidine sites in 
DNA, where two pyrimidine nucleotides are juxtaposed tandemly.5–7 Among these 
ultraviolet (UV) photolesions, cytosine-containing CPDs are known as the main 
mutagenic DNA damage, specifically inducing cytosine (C) ® thymine (T) base 
substitution mutations at dipyrimidine sites.8 However, studies on the quantitative 
relationship between the amount of CPD and the occurrence of mutation have been 
lacking so far. 
Evaluation of the amounts of UV photolesions has been performed through 
several methods such as chromatographic analyses, DNA breakage assays with 
enzymatic or chemical strand scission specific to UV photolesions, immunological 
assays, and HPLC with electrospray tandem mass spectrometry (HPLC-ESI-MS/MS) 
detection.6,9–13 The latter two methods are sensitive enough to detect physiologically 
significant, low amounts of UV photolesions, and one of the immunological assays, 
enzyme-linked immunosorbent assay (ELISA), is widely used because of its well 
established, conventional protocols and the general availability of monoclonal 
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antibodies highly specific and sensitive to CPDs and 64PPs.14,15 However, the 
quantification with immunological methods is not absolute but relative, so that it is 
difficult to compare between different photolesions and to determine the molecular 
amounts of the lesions with this approach alone. Although a pioneer work quantifying 
the absolute amounts of UV photolesions with an immunological assay was performed 
previously using calibrated DNA whose UV photolesion amounts were predetermined, 
the determination of the photolesion amounts in the calibrated DNA depended on 
indirect enzymatic assays whose sensitivities were relatively low.9 HPLC-ESI-MS/MS 
technology has solved these problems by enabling the direct determination of the 
absolute amounts of UV photolesions with high sensitivity, but this approach is limited 
by the expense of equipment specifically adjusted for the quantification of UV 
photolesions.6 
In the present study, we introduced to a conventional ELISA assay a set of UVR-
exposed DNA samples, for which the amounts of UV photolesions had been determined 
in advance with the HPLC-ESI-MS/MS method as a calibration standard for the 
estimation of the molecular amounts of CPDs and 64PPs in DNA. For the ELISA, 
TDM-2 and 64M-2 monoclonal antibodies were utilized because they can detect with 
high sensitivity CPDs and 64PPs formed at all kinds of dipyrimidine sequences, 
respectively, as shown previously,16 although the sensitivities may be not always equal 
among those dipyrimidine sequences. With this calibrated ELISA assay, we evaluated 
quantitatively, based on the molecular amounts of photolesions, the effects of these UV 
photolesions on the mutation induction in mouse skin exposed to UVC and UVB. 
 
Materials and Methods 
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Standard UVR-exposed DNA 
Calf thymus DNA (D1501, Sigma-Aldrich) dissolved in water at 400–500 µg/ml was 
exposed to 50, 100, 200, 300, 400 and 566 Jm-2 of UVB emitted from broadband UVB 
lamps (313 nm peak; FL20S.E, Toshiba, Japan; Fig. 1). The molecular amounts of UV 
photolesions produced in the DNA were determined with HPLC-ESI-MS/MS as 
described previously.11,12 
 
Mice, UVR irradiation and skin DNA preparation 
All procedures for the animal experiments including the husbandry, which were 
approved by the Institutional Animal Care and Use Committee of Tohoku University, 
were conducted according to the Fundamental Guidelines for Proper Conduct of Animal 
Experiment and Related Activities in Academic Research Institutions under the 
jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology of 
Japan and the Regulations for Animal Experiments and Related Activities at Tohoku 
University. The mice used were a transgenic mouse strain harboring l-phage-based 
lacZ mutational reporter genes.17 The UVB source used was the same as that used for 
the standard DNA. The UVC source was GL15 germicidal lamps (peak emission 254 
nm; Hitachi, Japan; Fig. 1). UVC and UVB dosimetry was performed with a UVX 
radiometer equipped with UVX-25 and UVX-31 sensors, respectively (UVP, San 
Gabriel, CA). For DNA damage analysis, two or four mice were exposed to UVC and 
UVB at each of several dose points in ranges of 25-300 and 100-3000 Jm-2, 
respectively. UVR irradiation and DNA preparations from the exposed mouse skin were 
performed as described previously.18 Briefly, the depilated dorsal skin of 8–12-week old 
mice was irradiated under anesthesia, excised immediately after euthanasia, and 
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separated into the epidermis and dermis with thermolysin after incubation at 55°C for 5 
min to inactivate endogenous DNA repair activities. Genomic DNA was extracted from 
each tissue and assayed for UV photolesions with ELISA. 
 
ELISA 
ELISA was performed with monoclonal antibodies TDM-2 and 64M-2 (prepared on our 
own; also available from Cosmo Bio Co., Ltd, Japan), which are specific respectively to 
CPDs and 64PPs,16 using the protocols described in the provider’s instructions 
(NMDND001 and 002, Cosmo Bio Co.) except for the use of biotin-goat anti-mouse 
IgG (H+L) (62-6540, Invitrogen) for the second antibody. The color development 
reactions of o-phenylene diamine by streptavidin-conjugated peroxidase (43-4323, 
Invitrogen) at 37°C were monitored without adding the stop solution of 2M H2SO4, by 
measuring continually absorbance at 450 nm (A450) in 2-min intervals up to 30 min 
using a microplate reader SUNRISE (TECAN, Austria). 
 
UV photolesion quantification 
In ELISA, each DNA sample derived from the UVR-exposed mouse skin was assayed 
quadruply along with the UVB-exposed standard DNA in the same plate. Based on the 
relationship between A450 and CPD or 64PP amounts, which was determined based on 
the data from the standard DNA by regression analysis (see Fig. 2A, C), the amounts of 
UV photolesions in the epidermal or dermal DNA from UVR-exposed mouse skin were 
estimated. 
 
Data on mutation induction in the UVR-exposed mouse skin 
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We analyzed previously the mutation induction kinetics in UVC- and UVB-exposed 
mouse skin by determining the mutant frequencies (MFs) of the lacZ transgene in the 
epidermis and dermis of UVR-exposed skin using the transgenic mice mentioned 
above.18–20 In the present study, those data were utilized to quantitatively evaluate the 
effects of photolesions on the modulation of mutation induction. 
 
Statistical Analyses 
Regression analysis was performed with computer software JMP Pro (SAS Institute 
Japan) and KaleidaGraph (Synergy Software, USA). 
 
Results and Discussion 
Preparation of calibration DNA for the absolute quantification of UV photolesions 
with ELISA 
Commercially available calf thymus DNA was dissolved in water and divided in 
aliquots, which were exposed to a series of UVB doses from broadband UVB lamps to 
prepare a set of standard DNA samples as calibrations for the quantification of the 
absolute amounts of UV photolesions. The molecular amounts of CPDs and 64PPs in 
each standard sample were determined with HPLC-ESI-MS/MS (Fig. 2A). These 
standard samples were also assayed with ELISA for the detection and quantification of 
CPDs and 64PPs, and A450 values were measured continually in the time course of the 
color development reaction of ELISA and showed the saturation of the reactions by 30 
min both for CPDs and 64PPs (Fig. 2B), indicating no need of further incubation or 
reaction-stopping agents to obtain stable chromatic values of absorbance. For the 
obtained UVB dose-A450 plots after 30 min incubation, regression curves were 
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determined (Fig. 2C). For CPDs, at any time point, even at the time points immediately 
after starting the reaction, the plot curve was not linear, but rather extended upwards 
with an upwardly convex curve (Fig. 2B, left), so that an exponential rise curve (y = 
a{1-exp(-bx)}; a, b: positive constant coefficients determined by the regression 
analysis) was adopted for the regression analysis because the A450 values seemed to 
approach a horizontal line asymptotically with the UVB dose increasing (Fig. 2C). On 
the other hand, plot curves for 64PPs showed linear increases at every time point except 
for the dose range greater than 400 Jm-2, at which the A450 values began to saturate (Fig. 
2B, right), so that a linear regression analysis was performed for the 64PP plots using 
the A450 values up to 400 Jm-2 (Fig. 2C). Hence, the estimation would be valid up to the 
amount of 64PPs produced in DNA exposed to 400 Jm-2 of UVB, which is roughly 50 
64PPs per million DNA bases, judging from Fig. 2A. 
Thus, regression analyses of the relationships between the UVB dose and A450 for 
CPDs and 64PPs were performed according to the following formulae: A = a{1-exp(-
bD)} and A = cD (A: A450, D: UVB dose), respectively, providing the values of the 
constant coefficients as a = 1.0375, b = 0.0065031 and c = 0.00099223, as shown in 
Fig. 2C. Since, in Fig. 2A, the relationships between the UVB dose and photolesion 
amount (molecules/106 bases) for CPDs and 64PPs were obtained by regression 
analyses as L = 1.3259D and L = 0.08914D, respectively (L: photolesion amount), the 
relationships between A450 and the photolesion amount for CPDs and 64PPs were 
expressed by the following formulae: L = -1.3259/b*ln(1-A/a) and L = 0.08914/c*A, 
respectively, which convert the A450 values to the absolute molecular amounts of 
photolesions independently of the UVR dose. Using the values of the constant 
coefficients obtained by the regression analyses shown in Fig. 2, the calibration 
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formulae for the estimation of the CPD and 64PP molecular amounts were derived as L 
= -203.9*ln(1-A/1.0375) and L = 89.84A, respectively. Thus, the calibration formulae 
for the estimation of the absolute photolesion amounts from the relative values 
evaluated in ELISA can be determined. However, the constant coefficients would vary 
assay by assay in ELISA, so that they should be determined in every ELISA assay by 
including the calibration DNA on the same ELISA plate with the samples under 
analysis. 
It should be noticed that the A450 values did not linearly increase with the UVB 
dose obviously for CPDs and, as seen at the highest dose, probably even for 64PPs (Fig. 
2B), although the molecular amounts of both photolesions increased proportionally with 
the UVB dose in the dose range examined here as determined with HPLC-ESI-MS/MS 
(Fig. 2A), confirming the previous studies.11,12 This observation would suggest that high 
densities of photolesions in DNA reduce the efficiency of antibody binding to the target 
moiety of photolesions, probably because of some steric hindrance by the formation of a 
lattice structure between antibodies and antigenic photolesions. The higher molecular 
densities in DNA of CPDs compared to 64PPs at the same dose (Fig. 2A) would have 
made the non-linear kinetics of dose-A450 curves more remarkable in the ELISA for 
CPDs than that for 64PPs (Fig. 2B). Thus, direct use of the values of absorbance from 
ELISA could be misleading in the estimation of the UV photolesion amounts. 
 
Quantification of UV photolesions in mouse skin exposed to UVC and UVB 
Mice were exposed on their hair-removed dorsal areas to UVR from UVC and UVB 
lamps up to 300 and 3000 Jm-2, respectively, and the amounts of CPDs and 64PPs 
produced in the skin epidermis and dermis were evaluated with ELISA (Fig. 3A). From 
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the obtained A450 values for the skin DNA samples, the absolute amounts of the UV 
photolesions were determined by converting the A450 values to molecular amounts of 
photolesions as mentioned above (see Fig. 2A and C), using the regression curves 
estimated from the standard UVB-exposed DNA samples which were assayed 
simultaneously in the same ELISA reaction plate (Fig. 3B). For the evaluation of the 
efficiencies of photolesion formation, the amounts of CPDs and 64PPs formed by a unit 
dose of UVR from UVC or UVB lamps were also estimated from the slopes of 
regression lines for the data points given in the graphs (Fig. 3B). For the regression, 
data points that deviated largely from the regression lines taken for the data points at 
lower doses were excluded from the analysis. The deviation would result from 
photoreversion of CPDs by shorter wavelength components21,22 and a limit of the 
calibration by the standard UVB-exposed DNA, which could cover reliably a certain 
range of the amount of each photolesion judging from Fig. 2A (ranges ≤500 CPDs/106 
bases and ≤50 64PPs/106 bases).  
The estimated amounts of the unit-dose CPD or 64PP formation in mouse skin 
exposed to UVR from the UVC or UVB lamps are given in Table 1 and Fig. 3C, along 
with those for the standard UVB-exposed DNA. The differences in the epidermis 
between the UVR sources indicate that the efficiencies of CPD and 64PP formation 
were about 10 times higher for UVC than for UVB, which is consistent with a previous 
report on naked DNA12 and the fact that the peak wavelength of the energy output of the 
UVC lamp (254 nm) is much closer to the peak absorption wavelength of DNA (260 
nm) than that of the UVB lamp (313 nm), although the UVR from UVB lamps was not 
purified to exclude the small amounts of UVC and UVA wavelengths by filtration (see 
Fig.1). The differences between the epidermis and dermis for the same UVR sources 
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should reflect the capacity of the epidermis to prevent UVR penetration to the dermis. 
Compared to the values for the epidermis, CPD and 64PP formations were reduced in 
the dermis to 14% and 8%, respectively, against UVC, and to 66% and 38%, 
respectively, against UVB (Fig. 3C and Table 1), indicating a higher protection ability 
of the epidermis for shorter UV wavelengths. These results are consistent with our 
previous observations of lower inductions of mutation in the dermis than in the 
epidermis of mouse skin exposed to UVC and UVB.18,19 In addition, the differences 
between the epidermis and naked DNA also shows the ability of the epidermal cornified 
layers to protect against UVB, which reduced CPD and 64PP formations to less than a 
fourth and a half, respectively (Fig. 3C and Table 1). Similar results were also reported 
previously for human skin and reconstituted skin.23,24 
We also noticed differences in the amount ratios of 64PPs to CPDs between the 
UVR sources or the skin tissues (Fig. 3D and Table 1). In all cases, 64PPs were 
produced less than CPDs at a molar basis and produced a fifth to a fifteenth as much as 
CPDs, consistent with previous studies using naked, cellular and skin DNA.9,11,12,25,26 
Moreover, UVC produced 64PPs at higher molar ratios of 64PP/CPD for both the 
epidermis and dermis than UVB, suggesting that 64PPs are formed preferably by 
shorter UV wavelengths compared to CPDs, which would be consistent with the lower 
64PP/CPD ratios in the dermis than in the epidermis observed in both UVC and UVB-
exposed skin (Fig. 3D, Table 1), because the epidermal layer should attenuate the 
shorter UV wavelengths more efficiently, as shown in Fig. 3C. The lower yield of 
64PPs at longer wavelengths may reflect the different photochemical mechanisms 
recently proposed for the two photolesions,27 in which 64PP formation should drop 
more remarkably as the wavelength increases than CPD formation. Another explanation 
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for the lower 64PP/CPD ratios would be the accelerated decrease in the amount of 
64PPs by their isomerization to Dewar isomers by UVB, which emits the wavelengths 
around 320 nm most effective for the photochemical isomerization reaction. However, 
in the present study, the estimation of the 64PP/CPD ratio was performed using the 
unit-dose amounts of photolesions determined with the data in the initial low dose 
range, which would not induce the isomerization sufficient to affect the 64PP/CPD ratio 
largely, as reported previously.28 
Interestingly, the 64PP/CPD molar ratios were remarkably different between the 
epidermis and naked DNA exposed to UVB (Fig. 3D, Table 1). The lower 64PP 
formation efficiency for naked DNA would reflect the influence of chromatin structure 
or other cellular environments in the epidermis on the formation of UV photolesions, 
which seems to enhance 64PP formation or to suppress CPD formation in the epidermis. 
Actually, it has been reported that the formation of CPDs in chromatin is restricted by 
the rotational position of dipyrimidines in DNA to the nucleosome surface, whereas 
64PP formation seems to be uniform within a nucleosome and rather prefers linker 
DNA regions,29 which might be responsible for the difference in the 64PP/CPD ratio 
between naked and epidermal DNA observed in Fig. 3D. 
 
Quantitative evaluation of mutation induction by photolesions in UVR-exposed 
mouse skin 
To analyze the relationship between the DNA damage amounts and mutation induction, 
data for the mutation induction kinetics in mouse skin exposed to UVC and UVB, 
which we have already reported previously,18–20 were reevaluated as shown in Fig. 4A. 
The efficiency of mutation induction, which is defined as mutagenicity here, was 
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estimated as a unit-dose increase of the mutant frequency (MF), namely, the slope of the 
MF increase, which was calculated by regression analysis for each MF increase curve 
shown in Fig. 4A (also given in Table 2 as UVR mutagenicity) although, for the 
epidermis, only the MF data points before the MF started to plateau were used for the 
analysis. In the epidermis, the response of mutation induction suppression (MIS) was 
evident after exposure to UVC or UVB more than a certain dose (Fig. 4A). MIS is an 
important tissue response that is characteristic of mutation induction in UVR-exposed 
skin, as we reported previously.19,30,31 As the quantifiable value for the MIS response, 
the minimum dose for MIS induction, namely the minimum MIS dose (MMISD), was 
used,30 and estimated to be 25 Jm-2 for UVC and 500 Jm-2 for UVB from the MF 
induction kinetics in the epidermis for each type of UVR (Fig. 4A). 
Because CPDs are the major UVR-specific DNA damage and are known to cause 
most of the mutations by UVR, at least, in DNA repair-proficient cells and skin,8,32 we 
focused on the mutagenicity of CPDs produced by each UVR source. To evaluate the 
CPD mutagenicity, the amounts of CPDs formed in a lacZ transgene by a unit dose of 
UVC and UVB were calculated as shown in Table 2, and the unit-dose mutagenicity of 
each UVR (UVR mutagenicity, Table 2) estimated from the slope of the regression lines 
in Fig. 4A was divided by the calculated value to determine the mutagenicity of a CPD 
produced by UVC and UVB in the epidermis and dermis (CPD mutagenicity, Table 2). 
The resultant CPD mutagenicities were significantly different between UVC and UVB 
in both skin tissues (Fig. 4B and Table 2). CPDs produced by UVB were more than 2-
fold mutagenic than those by UVC in the epidermis and this difference was larger in the 
dermis, which suggests that the properties of the CPDs produced by UVC and UVB 
might be different. In other words, UVB might produce more mutagenic CPDs than 
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UVC, although some differences in the cellular responses to these UVRs, such as the 
induction of DNA repair processes and/or proliferative/senescent/apoptotic responses, 
might have influenced the differences in CPD mutagenicity.33 It should also be 
mentioned that the CPD mutagenicity is determined based on the initial slope of 
mutation induction, that is, deduced from mutations induced in the low dose range of 
UVR, which means that the CPD mutagenicity is unlikely to reflect the cellular 
responses induced by higher doses of UVR. 
It was also noticed that CPDs in the dermis were less mutagenic than those in the 
epidermis, although they were induced by the same UVR sources (Fig. 4B and Table 2). 
This observation suggests a more efficient elimination of CPDs in the dermis by some 
biological processes such as DNA repair and apoptosis, which is, however, inconsistent 
with previous reports supporting a higher repair activity and apoptosis for the epidermis 
or keratinocytes.34–37 This discrepancy might be solved by supposing an efflux of UVR-
damaged fibroblasts from the UVR-exposed skin area along with an influx of 
undamaged ones from the surrounding intact dermis by post-irradiation cell migration, 
or by postulating an induction of premature senescence of damaged fibroblasts,38 which 
should stop DNA replication and prevent mutation induction in those cells because the 
fixation of mutation in DNA requires a UV photolesion bypass by DNA synthesis.39–41 
We also estimated the amounts of UV photolesions produced in the epidermis 
after exposure to 25 and 500 Jm-2 of UVC and UVB, the minimum doses to induce the 
MIS response in mouse epidermis, namely MMISD, as shown in Table 3 and Fig. 4D. 
Since MIS is an immediate response in the epidermis after UVR exposure, the amounts 
of DNA lesions instantly produced by UVR could be one of the determinants in the 
induction of the MIS response. The estimates in Table 3 suggest that about 100 CPDs or 
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15 64PPs per million bases in DNA could induce the MIS response, although the lesion 
amounts necessary for the induction by UVB were roughly twice as high as those by 
UVC (Fig. 4C and Table 3). It would be an important question which photolesion, CPD 
or 64PP, triggers the MIS response, or to what extent each photolesion contributes to 
the induction of the MIS response, which is, however, difficult to solve decisively with 
the data provided in the present study. 
 
The origin of the different mutagenicities of CPDs produced by UVC and UVB 
We found that UVB-induced CPDs were more mutagenic than UVC-induced ones in 
both the epidermis and dermis. This observation might suggest that CPDs were 
eliminated more efficiently by some biological processes such as DNA repair and 
apoptosis in the skin after exposure to UVC than to UVB. However, such differential 
responses to CPDs have not been demonstrated yet between UVC- and UVB-exposed 
skin or cells. 
Although CPDs can be formed at four different dipyrimidine sequences, TT, TC, 
CT and CC, only the latter three, cytosine-containing dipyrimidines can induce UVR-
specific C ® T mutations. The importance of cytosine-containing CPDs for the UVR 
mutagenesis has also been suggested previously.12,42 Cytosines in CPDs are unstable 
and easily deaminate to produce uracils (or thymines if their 5-position is 
methylated),4,43,44 which are known to produce C ® T mutations if translesion DNA 
synthesis (TLS) polymerase h bypasses these deaminated CPDs.4,45,46 The propensity of 
cytosine to deaminate is known to vary by the sequence context in which CPDs are 
placed. Cytosines in TC-CPDs formed in the 5’-TCG-3’ context have been shown to 
deaminate more easily than other TC- or CC-CPDs in other contexts as far as examined 
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in naked and chromatin DNA,47–49 thus making CPDs in the TCG context highly 
mutagenic compared to CPDs in the other sequence contexts. The TCG context includes 
a CpG motif, the target sequence of mammalian DNA methylation, with which the 
cytosine in the motif is methylated to produce 5-methylcytosine,50 and CpG methylation 
at dipyrimidine sites is known to enhance CPD formation by longer wavelength UVRs 
such as UVB and solar UVR,51–53 but not by UVC.53–55 This methyl CpG preference of 
the CPD formation by longer wavelength UVRs should cause more CPDs at the TCG 
context, resulting in the production of more mutagenic CPDs after skin exposure to 
UVB than to UVC, as observed in the present study (Fig. 4C). Accordingly, we reported 
previously that UVB induced in mouse epidermis the UVR-specific C ® T mutations in 
the TCG context at a higher ratio than did UVC.18 Thus, UVB could produce more 
mutagenic CPDs than UVC in the mammalian skin genome. 
 
Conclusion 
The introduction of calibration DNA to ELISA facilitated our estimation of the 
genotoxicity of UV photolesions on a molecular basis, revealing a remarkable variation 
of CPD mutagenicity depending on the UVR sources and the type of skin tissues. The 
UVR source-dependent variation would reflect the wavelength-dependent methyl CpG 
preference of CPD formation and the sequence context-dependent cytosine-deamination 
tendency of CPD. The tissue-dependent variation might result from a difference in the 
response to the genotoxicity of UVR photolesions between the epidermis and dermis: 
the former is known to respond with the MIS response, whereas the latter might respond 
with a premature senescence of damaged cells or a post-irradiation cell exchange 
between damaged and undamaged dermal areas. The ELISA analysis with calibration 
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DNA could help provide not relative but absolute quantitative estimations of UVR 
genotoxicity at a reasonable cost. 
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Table 1  Quantification of UV photolesions in UVC/UVB-exposed mouse skin 
UVR source Tissue/sample Unit-dose CPD formation a 
(CPDs/Mb/Jm-2) 
Unit-dose 64PP formation a 
(64PPs/Mb/Jm-2) 
64PP/CPD ratio 
(64PPs/CPD) 
UVC Epidermis 2.59 x 100 4.59 x 10-1 0.177 
 Dermis 3.70 x 10-1 3.64 x 10-2 0.098 
UVB Epidermis 2.99 x 10-1 4.14 x 10-2 0.138 
 Dermis 1.97 x 10-1 1.56 x 10-2 0.080 
 DNA b 1.33 x 100 8.91 x 10-2 0.067 
a Slopes of regression lines estimated in Fig. 2A and 3B. CPD, cyclobutane pyrimidine dimer; 64PP, pyrimidine(6-4)pyrimidone 
photoproduct; Mb, 106 bases. b Calf thymus DNA solution directly exposed to UVB and used as a standard in the present study. 
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Table 2  Evaluation of the mutagenicity of CPD induced in UVC/UVB-exposed mouse skin 
Tissue UVR source Unit-dose CPD formation  
per lacZ transgene a 
(CPDs/lacZ/Jm-2) 
UVR mutagenicity b 
(MF/Jm-2) 
CPD mutagenicity 
(MF/CPD) 
Epidermis UVC 1.56 x 10-2 1.20 x 10-5 7.71 x 10-4 
 UVB 1.79 x 10-3 3.27 x 10-6 1.82 x 10-3 
Dermis UVC 2.22 x 10-3 1.85 x 10-7 8.32 x 10-5 
 UVB 1.18 x 10-3 8.55 x 10-7 7.24 x 10-4 
a Estimates of the number of CPDs in a lacZ transgene formed by a unit dose of UVB or UVC, which were calculated 
from the values in Table 1, estimating the size of a lacZ transgene as 6000 bases. b Initial slopes of mutation induction 
estimated in Fig. 4A. MF, mutant frequency. 
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Table 3  Evaluation of UV photolesion amounts produced by minimum MIS-inducing dose of UVC/UVB in mouse epidermis 
Photolesion UVR source Unit-dose photolesion formation a 
(Lesions/Mb/Jm-2) 
MMISD b 
(Jm-2) 
MIS-inducing photolesion amount c 
(Lesions/Mb/MMISD) 
CPD UVC 2.59 x 100 25 64.8 
 UVB 2.99 x 10-1 500 149 
64PP UVC 4.59 x 10-1 25 11.5 
 UVB 4.14 x 10-2 500 20.7 
a Slopes of regression lines estimated in Fig. 3B. b Minimum MIS dose: minimum doses to induce the response of mutation induction 
suppression (MIS). c Calculated by multiplying the unit-dose photolesion formation by MMISD. 
 
 28 
Figure legends 
 
Fig. 1  Profiles of percent spectral outputs of UVC and UVB lamps used in the present 
study. Spectral energy outputs of each lamp were measured with a spectroradiometer 
(USR-45DA, Ushio Inc., Japan) at 1-nm intervals. 
 
Fig. 2  Quantification of UV photolesions in standard UVB-exposed DNA. (A) The 
amounts of CPDs and 64PPs at each dipyrimidine of TT, TC, CT and CC in DNA 
samples exposed to a series of UVB doses were determined with HPLC-MS/MS, 
summed up by each photolesion, and plotted. Error bars show standard deviations. 
Lines with an equation show linear regression curves (slopes: P < 10-10 for CPDs, P < 
10-8 for 64PPs). (B) ELISA reactions with the standard DNA samples were monitored 
by the absorbance at 450 nm at every 2 min up to 30 min for CPDs (left) and 64PPs 
(right). (C) Regression analysis was performed for the values obtained at 30 min in Fig. 
2B excluding the value at the highest dose for 64PPs. Error bars indicate standard 
deviations. Lines with an equation show regression curves (R2 > 0.99 for CPDs; P < 10-
7 for the slope of 64PPs). 
 
Fig. 3  Quantification of UV photolesions in mouse skin exposed to UVR from UVC or 
UVB lamps. (A) Dose response of UV photolesion formation estimated by ELISA. The 
amounts of CPDs and 64PPs in genomic DNA from mouse skin epidermis and dermis 
exposed to UVR from UVC (left) and UVB (right) lamps were estimated with ELISA 
and shown by the values of absorbance at 450 nm (A450). Each point is derived from a 
single mouse. (B) Dose-dependent UV photolesion formations shown by absolute 
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molecular amounts of CPDs and 64PPs. The A450 value for each data point given in A 
was converted to a molecular amount per million bases using the standard UVB-
exposed DNA, and given separately by CPDs (upper panels) and 64PPs (lower panels). 
The efficiencies of photolesion formation were estimated from the slopes of the 
regression lines for the data points labeled by colors (red and blue for epidermis and 
dermis, respectively). The equation for each regression line is given in the same color in 
each panel. (C) Unit-dose formation of UV photolesions in mouse skin exposed to UVR 
from UVC and UVB lamps. Molecular amounts of CPDs (left) and 64PPs (right) 
formed in the epidermis (dark) and dermis (light) by a unit-dose of UVC and UVB are 
given along with those in naked DNA (the standard DNA used for calibration) by UVB 
(oblique striped). Error bars show standard errors. (D) Ratios of 64PPs to CPDs formed 
in mouse skin and naked DNA exposed to UVR from UVC or UVB lamps. Symbols are 
the same as those in C. 
 
Fig. 4  Quantitative evaluation of the mutation induction kinetics in UVR-exposed 
mouse skin. (A) Quantification of mutation induction in UVC/UVB-exposed mouse 
skin. Mutation induction kinetics for UVC-exposed (upper) and UVB-exposed (lower) 
mouse skin were evaluated for the efficiencies of mutation induction by regression 
analysis. Data points used for the analysis are color-labeled (red for epidermis and blue 
for dermis), and equations for the regression lines are provided in the same colors in 
each panel. Error bars show standard deviations. (B) Mutagenicity of CPDs produced 
by UVC (dark) and UVB (light) in skin tissues. (C) Amounts of photolesions produced 
by the minimum dose of UVC (dark) and UVB (light) to induce the MIS response, 
which were estimated as 25 and 500 Jm-2, respectively, from the MIS induction kinetics 
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in the epidermis given in A. Error bars in B and C show standard errors. MF: mutant 
frequency, MMISD: minimum MIS dose. 
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